Description

Sihuan Pharmaceutical Holdings Group Ltd. functions as an investment holding company, primarily dedicated to the research, development, manufacturing, marketing, and distribution of pharmaceutical products across the People's Republic of China. Its drug portfolio encompasses a range of therapeutic areas, including oncology, metabolic disorders, and digestive system ailments. The company also diversifies its operations through investments in and sales of medical aesthetic products, the production of medical devices, property investments, undertaking medical construction initiatives, and preparing for new pharmaceutical manufacturing projects. Additionally, it delivers various services, such as informational support, general hospital services, hospital management, biotechnology promotion, and research and development in medical aesthetics. Founded in 2001, the firm is headquartered in Wanchai, Hong Kong.